There was a time when most people knew their corner pharmacist - like Mr. Gower in It's a Wonderful Life - and visits to the drug store included personal conversations to catch up on neighborhood and news, besides the dispensing of medications.
Diabetes Health recently submitted some questions to CVS Caremark Corporation regarding its "The State of the States: Adherence Report." The report compiled data from more than 50 million patients to track their level of adherence to drug prescriptions for four chronic diseases: diabetes, depression, high blood pressure, and high cholesterol.
There's nothing quite like wondering how you're going to pay for prescriptions. I find it odd that we usually don't know what our out-of-pocket cost will be until we're standing in front of the pharmacy staff and praying that we have enough in our wallet to cover it. I often feel like a reality show contestant waiting for the grand total. My pharmacy-based reality show would probably be called "The Biggest Payer," or perhaps "The Amazing Guess," or, aptly, "Survivor." If you've ever walked away from the pharmacy counter embarrassed, panicked, or depressed, you know the feeling I'm referring to. It's a pain no prescription can cure.
Boehringer Ingelheim and Eli Lilly have begun sales of Tradjenta, a drug for type 2 diabetes, in U.S. pharmacies. The drug (generic name linagliptin) comes in tablet form and is intended to compete with Amylin Pharmaceuticals' Byetta, which is injected, and Merck's Januvia, which also competes with Byetta. Both are well-established in the U.S. market.
Nipro Diagnostics, Inc., and NeuroMetrix, Inc., have announced that they will seek opportunities to sell their soon-to-be-introduced NC-stat® DPNCheckTM neuropathy test in retail medical clinics nationwide. The test, conducted onsite, evaluates neuropathies, including diabetic peripheral neuropathy (DPN).
The U.S. Food and Drug Administration has said that starting on November 18, 2011, it will restrict retail pharmacy sales of three diabetes drugs manufactured by GlaxoSmithKline: the stand-alone Avandia (rosiglitazone) and the combination drugs Avandamet (rosiglitazone and metformin) and Avandaryl (rosiglitazone and glimepiride).
The makers of "PhoneMyDoctor," a new telemedicine service, say it offers the ability integrate patient calls, doctor feedback, pharmacy ordering, and follow-up instructions into one documented record, using a medical practice's existing telephone equipment.
There's more to that little box of pen needles than meets the eye, according to Holly Hartshorn of UltiMed. In early March, UltiMed launched a 50-count box of UltiCare pen needles into the marketplace. We spoke to Holly to find out exactly what kind of thought goes into such a product before it appears on pharmacy shelves.
Jeff and Natalie Kolok live in northwestern Vermont with their three children: Naomi, 16, and Johanna and Nicholas, each ten years old. Both Johanna and Nicholas have type 1 diabetes, Johanna since age four and Nick since age six.
Ross Valley Pharmacy, tucked away inside a larger building of clinics, is not a big place, but it's very very busy. Its owner, Paul Lofholm, PharmD, has a vision of the pharmacist's role that goes far beyond simply putting pills in bottles. He sees pharmacists as integral members of the healthcare team who can fill the gaps in patients' education about their conditions and their medications.
Ross Valley Pharmacy, tucked away inside a larger building of clinics, is not a big place, but it's very very busy. Its owner, pharmacist Paul Lofholm, has a vision of the pharmacist's role that goes far beyond simply putting pills in bottles. He sees pharmacists as integral members of the healthcare team who can fill the gaps in patients' education about their conditions and their medications.
Nearly one in six people in the United States has no health insurance. If you have diabetes, that's a very tough position to be in. There are, however, resources that can cut the costs that you have been paying out of pocket for medicines and supplies.
The newest threat to patient health may not be the flu or other epidemics. It could be a major shortage of prescription drugs. The shortage has reached the level of a "national public health crisis," according to a survey conducted by the Institute for Safe Medication Practices (ISMP) this summer. Survey respondents said shortages in the past year were "the worst ever, without a glimmer of hope for any improvement in the near future."
A South African university pharmacologist has found that simultaneous consumption of metformin and grapefruit juice raises lactic acid to dangerous levels in rats (and conceivably in people) with type 2 diabetes. Too much acid in the blood can cause low pH levels that interfere with the body's metabolic functions. Conceivably, says Dr. Peter Owira, a pharmacologist at the University of KawZulu-Natal, such low levels could be fatal.
Drug companies spend billions of dollars on research, and it's obvious that they spend more billions on advertising. Well, according to the New York Times, they spend the most billions on giving nice things to doctors: pens, samples, banquets, trips, and educational opportunities among them. For doctors, in fact, there is a free lunch: Pharma companies spend as much as a billion a year just on lunches for doctors. And over 90 percent of doctors have accepted at least some of this largesse from the industry.
Physicians who treat people with type 2 diabetes face difficult choices when selecting the best medical therapy for each patient. The decision process is further complicated by the fact that because type 2 diabetes is a progressive disease, therapeutic agents that were initially successful may fail five or ten years later.
If your summer travels take you south of the border into Mexico, pharmacists say you should avoid the temptation of saving a few dollars by purchasing your medications at farmacias, which sell versions of American prescription drugs made in Mexico.
Diabetes treatments are now the leading driver of prescription drug spending growth, displacing lipid-lowering drugs, which tumbled in price after a reign of 10 years in the top position. Generic drugs are cutting the cost of treating high cholesterol.
In July, I flew from New York City to Phoenix to meet my new book agent. (Trust me, I would not have deliberately sought out 100-degree weather without good reason.) Always thinking ahead, I decided to bring along a fancy new bag specially insulated to keep my insulin cool. Alas, either the bag failed me, or I failed the bag.
The FDA has spoken: the heart risk warnings on labels of Avandia (rosiglitazone) and Actos (pioglitazone) will now be surrounded by an emphatic black outline known as a black box. Black boxes will also be added to the warnings on Avandaryl (rosiglitazone and glimepiride), Avandamet (rosiglitazone and metformin), and Duetact (pioglitazone and glimepiride).
The September 2007 Journal of the American Medical Association (JAMA) has published two new studies, one a meta-analysis of Avandia (rosiglitazone) and the other a meta-analysis of Actos (pioglitazone).
Americans spend 275 billion dollars on prescription medicines every single year, sixty percent of it on generics. But in the next five years, the twenty-year patents are going to expire on enough brand-name medicines to account for about 60 billion dollars of that total. And the generics that spring up to replace those drugs will be thirty to eighty percent cheaper.
On December 13, 2005, Keith Scofield visited a Wal-Mart pharmacy in
Frederick, Maryland, and ordered over-the-counter Humulin R
(u-100). Instead, he was allegedly given Humulin R (u-500), a prescription
drug that contains five times the insulin of the requested
On July 30, 2007, a Food and Drug Administration (FDA) panel voted 22 to 1 to keep Avandia on the market, right after agreeing by a vote of 20 to 3 that Avandia does increase heart risks. Now the FDA will decide what kind of warning should appear on the Actos and Avandia labels. It has already called for a black box warning, the sternest possible, on Avandia.
Analysis of several recent studies indicates that Avandia (rosiglitazone), a type 2 diabetes medication that's been taken by more than six million people worldwide, is associated with a 43 percent increased risk of heart attack and with a borderline-significant increased risk of heart attack-related death.
Because of recent changes in airline regulations concerning the transportation of medication, diabetics have more to lose than just their lotion or soda. Now more than ever, it is important to know how to notify security and flight personnel of your medical needs, what documentation to bring, and where to find supplies if yours are damaged.
For people who develop type 1 diabetes, the autoimmune attack on beta cells actually starts up to ten years before diabetes is diagnosed, when autoantibodies first appear in the blood and begin attacking the beta cells.
In 1997, Minnesota became the first of a handful of states to pass a law requiring drug makers to disclose payments made to doctors. Its records reveal that over twenty percent of the state’s physicians have received such payments, generally for giving speeches about drugs to other doctors.
Valley Forge, Pa. - Good Neighbor Pharmacy®, a 25 year old network of independently owned pharmacies with over 2,700 locations nationwide, is proud to be the “Official Medical Supply” sponsor of the 2007 Ironman 70.3 California and seven other Ironman events.
A long-term study published in a recent issue of the Journal of Palliative Medicine found that Eli Lilly’s non-narcotic prescription drug Cymbalta (duloxetine HCl) is as safe and well-tolerated as current routine care that uses one or more medications for the management of pain caused by diabetic nerve damage. Study findings also show that Cymbalta did not adversely affect the progression of diabetes or many of the complications associated with the illness, such as damage to the nerves, kidneys and eyes.
On February 28, 2006, sanofi-aventis announced that its fast-acting
Apidra (insulin glulisine [rDNA origin] injection) is now available by
prescription in the United States. Apidra was granted FDA approval in
New Zealand researchers say that in clinical trials of people with type 2 diabetes, Actos as stand-alone therapy or in combination with metformin, repaglinide, insulin or a sulphonylurea induced “both long- and short-term improvements in [blood glucose] control and serum lipid profiles.”
When it’s time to restock your diabetes medications and supplies, have
you ever wished that you didn’t have to make that trip to the pharmacy?
Wouldn’t you like to avoid the lines, the traffic or parking hassles,
and having to find your prescription for the refill?
It was the belle of the ball at last summer’s ADA Scientific Sessions in San Diego. Now it appears that muraglitazar (Pargluva) is clinging to life after a scathing report recently published by the Journal of the American Medical Association.
Many pump manufacturers have online stores where you can order and pay for
your infusion supplies. In addition to manufacturer Web sites, services are
offered by Advantage Rx, CCS Medical, Fifty 50 Pharmacy, Focus Pharmacy, Logimedix
and National Diabetic Pharmacy. In Canada, supplies can be obtained from AutoControl
Actos (pioglitazone HCl) is an oral agent for type 2 diabetes belonging to the thiazolidinedione (TZD) class of drugs. TZDs help lower insulin resistance, a core dysfunction in people with type 2. They act by helping the body use its available amounts of insulin more effectively. Actos is known as an “insulin sensitizer” because it directly targets insulin resistance, a condition in which the body cannot use the insulin it produces efficiently.
Actos, an insulin sensitizer in the glitazone class of type 2 oral diabetes medications, was found to reduce carotid artery intima-media thickness (IMT) as well as insulin resistance in a German study.
Convenience! No insurance or Medicare claims! No paperwork!
These are just some of the reasons that many
people with diabetes order their medications and
supplies through the mail instead of picking them
up at the pharmacy.
Many people with diabetes suspect that the insulin they get by mail sometimes has lost its effectiveness. Now, a study has proven their suspicions are probably true, causing the medical community to question mail-order pharmacies and bring people back to their community pharmacies, where face-to-face treatment delivers to them the best care possible.
One year ago, I was standing in line at a local pharmacy to purchase a prescription drug for my wife. The woman in front of me had given the pharmacist a prescription for a mild agent to help her son sleep. This drug is neither essential nor even clearly effective. As the pharmacist gave the woman the bottle of 30 pills, he asked her for $204.
Two new drugs have received approval from the U.S. Food and Drug Administration (FDA) for the treatment of type 2 diabetes. In clinical trials, Avandia (rosiglitazone maleate) and ACTOS (pioglitazone hydrochloride) lowered blood sugars an average of 76 mg/dl and 95 mg/dl respectively, when compared to a placebo.
Dori Linnell of Eureka, Montana, would do anything for Tel, her 5-year-old son with diabetes. With diligence, knowledge and love, she has kept his HbA1cs in the nearly perfect range of 6.8 to 7.0 %. Linnell is obviously doing what works but always looking for something that may work better. She read about BetaFast, a product that is said to help people with diabetes control their blood sugars. BetaFast is made from the leaf extract of the herb Gymnema sylvestre, a climbing plant found in India. Always a believer in herbs, she wanted to try it with Tel.
Asheville, North Carolina recently saved $25,000 in treating diabetes-related conditions under its self-funded health insurance program. The city owes its savings to a novel pilot project conceived by the North Carolina Center for Pharmaceutical Care in cooperation with Mission St. Joseph's Hospital System and local pharmacies.
After years of searching for diabetic skin care treatments, Anastasia Marie Chehak developed a line of products called Diabetic Pure Skin TherapyÂ¨. Chehak wanted to create a skin care system that would provide immediate relief as well as long-term therapeutic use. Chehak is a diabetes educator, registered dietitian, clinical nutritionist and a diabetic herself. In treating patients, she found that the typical over-the-counter skin creams didn't do much to improve the condition of her patients' skin.
Your pharmacist and his staff screen a new prescription for errors, then enter the data into the computer. If a problem is noted the pharmacist will contact your physician. The prescription is dispensed to you and a face-to-face counseling session informs you how to take the medicine correctly, what possible side effects or adverse effects to be aware of, and what to do about a missed dose. Some computer programs also print out an information sheet about your prescription.
Introduction: It was a long, difficult, and confusing road that lead me to the conclusion that as a person with diabetes (type I for 45 years), I should take vitamin, mineral, and trace element (micronutrient) supplements daily. My educational background, like that of most other health care providers, did not include much clinical information about the need for micronutrients. Most of the information presented concerned biochemical effects (the effects of vitamins on the chemical reactions of cells) or deficiency states due to an unbalanced diet. I can remember my professor summarizing vitamin use by saying "the vast majority of people in the United States don't need to take daily vitamin supplements, as long as they consume well-balanced and nutritious meals each day." He also emphasized the lack of long-term clinical studies about micronutrient supplementation. My professor categorized the people who probably needed supplements as: children during growth stages, pregnant and lactating women, elderly patients, individuals with specific vitamin deficiencies, patients with chronic conditions, alcoholics, individuals under stress, and those who did not follow a well-balanced diet. I added up all the people in these categories and realized that a relatively high percentage of the total US population might need daily supplements.
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health.
Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.